Treatment options for advanced hepatocellular carcinoma (HCC) include immune checkpoint inhibitors (ICIs) such as anti-PD1, but not all patients with nonalcoholic steatohepatitis (NASH)-driven HCC respond to immunotherapy. A new study in Gut elucidates the role of neutrophils in NASH-HCC and ...
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law...
https://doi.org/10.1016/j.omtn.2019.12.023Get rights and content Under a Creative Commons license open accessDrug repositioning offers new clinical applications for existing drugs with shorter approval processes and lower costs and risks than de novo experimental drug development. The Fufang-Biejia-...
https://doi.org/10.1016/j.ccell.2014.11.011Get rights and content Under an Elsevier user license open archive Refers to Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage Cancer Cell, Volume 26, Issue 6, 8 December 2014, Pages 826-839 Krishna...
Sections Figures References Abstract Material and Methods Results Discussion Conclusion Availability of data and materials Abbreviations References Acknowledgements Funding Author information Ethics declarations Additional information Supplementary Information Rights and permissions About this article AdvertisementCancer...
HCC - Annexure Annual Return FY 2017-18(MGT 7) HCC Annual Return FY 2017-18 RIGHTS ISSUE – 2023-2024 Rights Issue Documents Monitoring Agency Report HCC Post Ballot - 2019 HCC Postal Ballot Notice HCC Postal Ballot Form HCC Postal Ballot Result...
Rights and permissions Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, ...
Rights and permissions This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the mate...
Rights and permissions Reprints and permissions About this article Cite this article Huang, D.Q., El-Serag, H.B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 18, 223–238 (2021). https://doi.org/10...
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such...